Bryant Woods Investment Advisors’s AbbVie ABBV Stock Holding History

Bryant Woods Investment Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,561	Closed	-$277K	–	50
2024 Q4	$277K	Buy	1,561 +14	+0.9%	+$2.57K	0.13%	45
2024 Q3	$306K	Buy	1,547 +25	+2%	+$4.67K	0.16%	39
2024 Q2	$227K	Buy	1,522 +22	+1%	+$3.64K	0.17%	39
2024 Q1	$273K	Sell	1,500 -130	-8%	-$22.4K	0.16%	38
2023 Q4	$253K	Buy	1,630 +108	+7%	+$15.7K	0.16%	39
2023 Q3	$227K	Buy	+1,522	New	+$223K	0.17%	39

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bryant Woods Investment Advisors's ABBV Position: Q1 2025 in Review

Bryant Woods Investment Advisors sold out of AbbVie (ABBV) in Q1 2025, closing a stake of 1,561 shares — an estimated $277K sold.

Bryant Woods Investment Advisors first reported a position in ABBV in Q3 2023 and held it in 6 quarters. The position peaked at $306K in Q3 2024. 3,820 funds tracked by Wall St. Rank hold ABBV as of Q1 2025.

Bryant Woods Investment Advisors reported no remaining AbbVie position as of Q1 2025 after selling out during the quarter.
Bryant Woods Investment Advisors sold 1,561 AbbVie shares in Q1 2025, an estimated $277K.
Bryant Woods Investment Advisors first reported a position in AbbVie in Q3 2023 and held it in 6 quarters.
Bryant Woods Investment Advisors's AbbVie position peaked at $306K in Q3 2024.
3,820 funds tracked by Wall St. Rank held AbbVie as of Q1 2025.

Based on Bryant Woods Investment Advisors's 13F filing for Q1 2025, filed 30 Apr 2025.